> For the complete documentation index, see [llms.txt](https://bens-disorganisation.gitbook.io/anzca-rga-notes/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://bens-disorganisation.gitbook.io/anzca-rga-notes/curriculum/2.-rga-clinical-fundamentals/2.2-general-anaesthesia-and-sedation.md).

# 2.2 General Anaesthesia and Sedation

<details>

<summary>GS_1.4 Discuss the indications for sedation and the requirements for safe practice of procedural sedation, both within and outside the operating room, refer to ANZCA professional document: PG09(G) Guideline on sedation and/or analgesia for diagnostic and interventional medical, dental or surgical procedures 2014.</summary>

#### Indications for Sedation and Requirements for Safe Practice of Procedural Sedation

**Indications for Sedation**

* **Facilitate Patient Comfort and Cooperation:**
  * Reduce anxiety and distress during diagnostic, interventional, or surgical procedures.
  * Minimize pain, discomfort, and psychological trauma.
* **Immobility Requirements:**
  * Ensure patient stillness for precise procedures (e.g., imaging, dental work, or endoscopic interventions).
* **Avoid General Anaesthesia:**
  * Provide sedation as a less invasive alternative to general anaesthesia when appropriate.
* **Special Populations:**
  * Pediatric patients, individuals with developmental delays, or those with procedural phobia who may benefit from sedation for compliance.

**Requirements for Safe Practice of Procedural Sedation**

(Referencing **ANZCA PG09(G) Guideline on Sedation, 2023**)

1. **Staffing and Competency:**
   * **Sedationist Qualifications:** Practitioners must have training and competencies outlined in the guideline, including airway management and life support skills.
   * **Team Composition:** Minimum staff includes a proceduralist, sedationist, and assistant with defined roles. For moderate sedation or complex cases, additional support may be required.
2. **Patient Assessment and Selection:**
   * Comprehensive pre-sedation assessment to identify risks (e.g., comorbidities, obstructive sleep apnoea, ASA status).
   * Evaluate airway risk, fasting status, and patient-specific vulnerabilities (e.g., age, frailty, history of adverse sedation reactions).
3. **Informed Consent:**
   * Obtain consent detailing the sedation process, risks, and benefits.
   * For pediatric patients, involve parents/guardians and consider child assent when appropriate.
4. **Monitoring Standards:**
   * **Continuous Monitoring:** Oxygen saturation (pulse oximetry), heart rate, respiratory rate, and blood pressure.
   * **Advanced Monitoring:** Use capnography for moderate sedation, particularly in high-risk patients.
   * Regular assessment of sedation depth and patient response to verbal/tactile stimulation.
5. **Safety Equipment:**
   * Ensure availability of resuscitation equipment (oxygen supply, suction devices, airway adjuncts).
   * Emergency drugs (e.g., naloxone, flumazenil) and intravenous access for moderate sedation or deeper levels.
6. **Environment and Facility Requirements:**
   * Adequate space for patient monitoring and resuscitation.
   * Staff training in emergency response and established escalation protocols.
   * For pediatric sedation, settings must have age-appropriate equipment and personnel.
7. **Pharmacological Management:**
   * **Medication Selection:** Use agents with predictable pharmacokinetics and rapid reversibility.
   * **Caution with Polypharmacy:** Avoid combinations leading to synergistic deep sedation unless appropriately skilled.
8. **Risk Mitigation:**
   * **Prevent Unintended Deep Sedation:** Regularly reassess sedation depth and prepare for escalation to general anaesthesia if needed.
   * **Special Populations:** Extra caution with children, pregnant women, and patients with obesity or OSA.
9. **Recovery and Discharge:**
   * Supervised recovery in a designated area until predefined discharge criteria are met.
   * Patients discharged only when they demonstrate stable vital signs, return of airway reflexes, and orientation.
   * Provide written post-discharge care instructions and ensure patient escort by a responsible adult.
10. **Documentation and Quality Assurance:**
    * Maintain accurate records of sedation plans, medication dosages, monitoring data, and recovery details.
    * Regular audit and compliance with jurisdictional reporting requirements for sedation-related morbidity or mortality.

***

#### Key Principles

* The goal of procedural sedation is to provide safe, effective care while avoiding complications related to unanticipated deep sedation.
* Adherence to guidelines such as ANZCA PG09(G) ensures best practices for patient safety and procedural success.

</details>

<details>

<summary>GS_1.6 Discuss indications, contraindications and other patient, surgical and anaesthetic factors influencing choice of agents for: <br>• Induction of anaesthesia <br>• Maintenance of anaesthesia <br>• Muscle relaxation and reversal <br>• Management of postoperative nausea and vomiting <br>• Pain management</summary>

**Induction of Anaesthesia**

* **Indications**:
  * Rapid loss of consciousness for airway control and surgical preparation.
  * Agents selected based on speed of onset, hemodynamic stability, and patient-specific factors.
* **Contraindications**:
  * Propofol: Caution in hemodynamic instability or allergy.
  * Etomidate: Avoid in adrenal insufficiency.
  * Ketamine: Avoid in patients with raised intracranial pressure (ICP) or severe cardiovascular disease.
* **Patient/Surgical/Anaesthetic Factors**:
  * Hemodynamics: Choose etomidate or ketamine for unstable patients.
  * Airway status: Consider rapid-sequence induction for aspiration risk.
  * Comorbidities: Adjust agents for conditions like epilepsy, obesity, or pregnancy.

**Maintenance of Anaesthesia**

* **Indications**:
  * Continuous sedation, amnesia, and immobility throughout surgery.
* **Contraindications**:
  * Volatile agents (e.g., sevoflurane): Caution in malignant hyperthermia.
  * Intravenous agents: Avoid high-dose propofol in prolonged sedation (propofol infusion syndrome).
* **Patient/Surgical/Anaesthetic Factors**:
  * Procedure duration: IV agents for short cases, volatile agents for longer cases.
  * Comorbidities: Adjust volatile agents for COPD or severe asthma.
  * Positioning: Optimize ventilation for prone or lateral positions.

**Muscle Relaxation and Reversal**

* **Indications**:
  * Facilitation of tracheal intubation and surgical field optimization.
* **Contraindications**:
  * Depolarizing agents (e.g., suxamethonium): Avoid in hyperkalemia, burns, or neuromuscular disorders.
  * Non-depolarizing agents: Caution in severe renal or hepatic impairment (e.g., vecuronium).
* **Patient/Surgical/Anaesthetic Factors**:
  * Duration: Short-acting agents for brief procedures; long-acting for prolonged cases.
  * Reversal: Consider neostigmine or sugammadex based on agent and residual paralysis.

**Management of Postoperative Nausea and Vomiting (PONV)**

* **Indications**:
  * Prevent PONV in high-risk patients using multimodal prophylaxis.
* **Contraindications**:
  * 5-HT3 antagonists: Caution in QT prolongation.
  * Steroids (e.g., dexamethasone): Avoid in poorly controlled diabetes or active infection.
* **Patient/Surgical/Anaesthetic Factors**:
  * Risk factors: Female gender, non-smoking status, and volatile agents increase PONV risk.
  * Surgery type: Higher risk in laparoscopic or ENT procedures.

**Pain Management**

* **Indications**:
  * Relieve acute postoperative pain and facilitate recovery.
* **Contraindications**:
  * Opioids: Avoid in opioid-tolerant patients or those with respiratory depression risk.
  * NSAIDs: Contraindicated in renal failure, bleeding risk, or gastric ulcers.
* **Patient/Surgical/Anaesthetic Factors**:
  * Pain severity: Tailor multimodal approaches combining opioids, NSAIDs, and regional techniques.
  * Surgical site: Regional anesthesia for specific areas (e.g., neuraxial blocks for lower limb surgery).
  * Comorbidities: Adjust for chronic pain, obesity, or substance use disorders.

This structured approach emphasizes balancing efficacy, safety, and patient needs to optimize anaesthetic care.

</details>

<details>

<summary>GS_1.7 Describe alterations to drug response in the following sub-groups: <br>• Extremes of age <br>• Pregnancy and lactation <br>• Drug addiction <br>• Opioid tolerance <br>• Cardiac disease <br>• Hepatic impairment <br>• Renal impairment <br>• Critically ill patients, including the trauma patient</summary>

**Extremes of Age**

* **Neonates and Infants**:
  * Reduced metabolism and clearance due to immature hepatic and renal function.
  * Altered protein binding increases free drug concentrations.
  * Increased sensitivity to opioids and neuromuscular blockers due to immature receptor systems.
* **Elderly**:
  * Reduced hepatic and renal function prolongs drug half-life.
  * Increased sensitivity to sedatives and opioids due to changes in receptor sensitivity.
  * Decreased plasma protein levels lead to higher active drug fractions.

**Pregnancy and Lactation**

* **Pregnancy**:
  * Increased cardiac output and blood volume dilute drug concentrations.
  * Enhanced hepatic enzyme activity alters metabolism (e.g., increased clearance of propofol).
  * Reduced gastric emptying delays oral drug absorption.
  * Drugs cross the placenta; consider fetal safety (e.g., avoid teratogenic agents).
* **Lactation**:
  * Lipophilic drugs can transfer into breast milk; assess risk-benefit for the neonate.

**Drug Addiction**

* **Altered Pharmacokinetics**:
  * Chronic use of substances (e.g., alcohol, cocaine) induces hepatic enzymes, increasing metabolism of some drugs.
* **Altered Pharmacodynamics**:
  * Desensitization or downregulation of receptors reduces efficacy (e.g., opioids).
  * Higher doses often required for effective anesthesia.

**Opioid Tolerance**

* **Reduced Analgesic Effect**:
  * Tolerance develops due to receptor desensitization and downregulation.
  * Increased opioid doses or adjunctive agents (e.g., ketamine) often required.
* **Cross-Tolerance**:
  * Partial tolerance to other opioids may occur.

**Cardiac Disease**

* **Reduced Cardiac Output**:
  * Impaired drug delivery to the liver and kidneys reduces clearance.
  * Increased sensitivity to cardiovascular depressants (e.g., propofol, volatile agents).
* **Altered Volume of Distribution**:
  * Fluid retention may dilute water-soluble drugs, reducing efficacy.

**Hepatic Impairment**

* **Reduced Drug Metabolism**:
  * Decreased phase I reactions (e.g., oxidation, reduction); phase II usually preserved.
  * Prolonged half-life of hepatically metabolized drugs (e.g., midazolam, opioids).
* **Increased Drug Sensitivity**:
  * Reduced protein binding elevates free drug levels.
  * Risk of hepatic encephalopathy with certain agents (e.g., benzodiazepines).

**Renal Impairment**

* **Reduced Clearance**:
  * Accumulation of renally excreted drugs (e.g., morphine metabolites, aminoglycosides).
  * Prolonged duration of action and increased risk of toxicity.
* **Altered Drug Binding**:
  * Uremic toxins displace drugs from protein binding sites, increasing free drug levels.

**Critically Ill Patients, Including Trauma Patients**

* **Hyperdynamic Circulation**:
  * Enhanced drug clearance due to increased cardiac output.
* **Hypoperfusion**:
  * Impaired hepatic and renal clearance in shock states.
* **Altered Volume of Distribution**:
  * Fluid shifts (e.g., edema, third spacing) dilute hydrophilic drugs, requiring dose adjustments.
* **Inflammation and Organ Dysfunction**:
  * Sepsis-induced alterations in drug metabolism and excretion.
  * Protein binding affected by hypoalbuminemia, increasing free drug levels.
* **Trauma-Specific Factors**:
  * Hypovolemia and acidosis alter drug distribution and receptor activity.
  * Coagulopathy influences response to anticoagulants and reversal agents.

Tailoring drug selection and dosing to these sub-groups ensures safety and efficacy while minimizing adverse effects.

</details>

<details>

<summary>GS_1.9 Discuss the aetiology of and measures to prevent intra-operative awareness under general anaesthesia and methods to monitor depth of anaesthesia</summary>

***

#### **Aetiology of Intraoperative Awareness**

Intraoperative awareness occurs when a patient becomes conscious during surgery and may recall the event afterward. Common causes include:

**1. Anaesthetic-Related Causes**

* **Inadequate Drug Delivery:**
  * Equipment malfunction (e.g., vaporizer failure, disconnection of intravenous lines).
  * Incorrect dosing of anaesthetic agents, particularly in high-risk cases.
* **Drug Tolerance or Resistance:**
  * Chronic opioid or sedative use leading to higher anaesthetic requirements.
  * Genetic variability affecting drug metabolism or response.

**2. Patient-Related Factors**

* **High Risk for Awareness:**
  * Emergency surgery (e.g., trauma, obstetrics) where rapid sequence induction limits time for anaesthesia onset.
  * Hemodynamic instability requiring reduced anaesthetic dosing.
* **Comorbidities:**
  * Reduced cardiac output or shock states impairing drug distribution and effect.
  * Patients with obstructive sleep apnoea or obesity requiring altered dosing.

**3. Surgical Factors**

* **High-Stimulation Procedures:**
  * Surgery with intense nociceptive stimuli (e.g., sternotomy, neurosurgery).
* **Minimal Anaesthetic Use:**
  * Techniques requiring reduced anaesthetic depth (e.g., cardiac surgery with cardiopulmonary bypass).

***

#### **Measures to Prevent Intraoperative Awareness**

**1. Preoperative Planning**

* **Identify High-Risk Patients:**
  * Review history for prior awareness, chronic pain syndromes, or substance use.
* **Individualize Anaesthetic Plan:**
  * Adjust dosages based on patient comorbidities, weight, and surgical requirements.

**2. Intraoperative Measures**

* **Appropriate Dosing:**
  * Ensure adequate induction with hypnotic agents.
  * Maintain sufficient maintenance anaesthesia with volatile agents, intravenous infusions, or balanced techniques.
* **Equipment Checks:**
  * Verify proper functioning of vaporizers, infusion pumps, and monitoring devices before surgery.
* **Neuromuscular Blockade Awareness:**
  * Avoid relying solely on patient immobility; combine with measures to ensure unconsciousness.
* **Prevention in Specific Cases:**
  * Use high-dose opioids, benzodiazepines, or scopolamine for patients at risk of reduced anaesthetic dosing.

**3. Postoperative Measures**

* **Early Detection:**
  * Conduct postoperative interviews to identify potential awareness experiences.
* **Support and Counselling:**
  * Provide psychological support to minimize the risk of post-traumatic stress disorder (PTSD).

***

#### **Methods to Monitor Depth of Anaesthesia**

**1. Clinical Monitoring**

* **Hemodynamic Parameters:**
  * Blood pressure and heart rate changes may indicate inadequate anaesthesia.
* **Movement:**
  * Spontaneous or reflex movements can signal insufficient anaesthetic depth.

**2. EEG-Based Monitors**

* **Bispectral Index (BIS):**
  * Calculates a numerical index (0-100) to estimate anaesthetic depth; <60 suggests adequate depth.
* **Entropy Monitoring:**
  * Measures cortical and subcortical activity; lower values indicate deeper anaesthesia.
* **Patient State Index (PSI):**
  * Derived from EEG to provide a measure of awareness likelihood.

**3. Auditory Evoked Potentials (AEPs)**

* **Middle Latency AEPs:**
  * Reflect brainstem and cortical response to auditory stimuli; less commonly used but sensitive.

**4. End-Tidal Agent Monitoring**

* **End-Tidal Volatile Agent Concentration:**
  * Ensures adequate volatile anaesthetic levels based on minimum alveolar concentration (MAC) values.

**5. Neuromuscular Monitoring**

* **Train-of-Four (TOF):**
  * Ensures complete paralysis without relying on immobility for depth of anaesthesia assessment.

</details>

<details>

<summary>GS_1.12 Discuss the potential causes and management of failure to wake from anaesthesia</summary>

**Potential Causes**

**1. Anaesthetic-Related Factors**

* **Prolonged Drug Effect:**
  * Overdose of volatile or intravenous anaesthetics.
  * Delayed clearance due to hepatic or renal impairment.
  * Prolonged neuromuscular blockade (e.g., inadequate reversal, pseudocholinesterase deficiency with suxamethonium).
* **Drug Interactions:**
  * Potentiation of anaesthetic agents by pre-existing medications (e.g., opioids, benzodiazepines).

**2. Patient-Related Factors**

* **Neurological Issues:**
  * Pre-existing conditions (e.g., dementia, cerebrovascular disease).
  * Acute events (e.g., stroke, hypoxic brain injury, seizure, raised intracranial pressure).
* **Metabolic Disorders:**
  * Hypoglycemia or hyperglycemia.
  * Electrolyte imbalances (e.g., hyponatremia, hypercalcemia).
  * Hypothermia causing slowed drug metabolism and neurological depression.
* **Systemic Factors:**
  * Hypoxia or hypercapnia.
  * Hemodynamic instability (e.g., hypotension, shock).
  * Sepsis or severe infection.

**3. Surgical or Procedure-Related Factors**

* Prolonged surgery with high drug dosages.
* Brain or spinal cord involvement in surgery (e.g., neurosurgical procedures).
* Postoperative complications such as hemorrhage or edema.

**4. Other Causes**

* Equipment malfunction (e.g., residual inhalational agents due to circuit failure).
* Rare conditions like malignant hyperthermia or atypical drug metabolism.

***

**Management**

**1. Immediate Assessment**

* **Airway, Breathing, Circulation:**
  * Ensure airway patency, adequate ventilation, and hemodynamic stability.
  * Check oxygenation (SpO₂, ABG) and ventilation (capnography).
* **Neurological Status:**
  * Assess pupil size and reactivity, motor responses, and Glasgow Coma Scale (GCS).
  * Check for focal neurological signs indicating stroke or other acute events.

**2. Investigations**

* **Laboratory Tests:**
  * Blood glucose, arterial blood gas (ABG), and electrolyte panel.
  * Renal and liver function tests.
  * Neuromuscular monitoring to exclude residual blockade (e.g., train-of-four ratio).
* **Imaging:**
  * CT or MRI brain if neurological cause suspected.

**3. Interventions**

* **Reversal Agents:**
  * Administer naloxone for opioid overdose or flumazenil for benzodiazepine sedation.
  * Administer sugammadex or neostigmine with glycopyrrolate for residual neuromuscular blockade.
* **Correct Metabolic Derangements:**
  * Treat hypoglycemia with dextrose or electrolyte imbalances with appropriate replacements.
  * Rewarm hypothermic patients with forced-air warming systems.
* **Optimize Hemodynamics:**
  * Treat hypotension with fluids or vasopressors.
  * Ensure adequate oxygen delivery.

**4. Specialist Consultation**

* Involve neurologists, intensivists, or toxicologists if no immediate improvement.
* Transfer to ICU for advanced monitoring and support if required.

**5. Prevention**

* Optimize patient condition preoperatively, considering comorbidities and medication interactions.
* Titrate anaesthetic agents appropriately, especially in high-risk populations.
* Ensure proper neuromuscular monitoring and reversal at the end of surgery.
* Vigilant monitoring in PACU to detect early signs of delayed recovery. "

</details>

<details>

<summary>GS_1.15 Discuss the management and postoperative follow up of a patient who reports intraoperative awareness under general anaesthesia</summary>

#### **1. Immediate Management**

**Recognition and Support**

* **Acknowledge the Report:**
  * Treat the patient’s report seriously and without skepticism.
* **Provide Empathy and Reassurance:**
  * Validate the patient’s experience and express genuine concern.

**Initial Assessment**

* **Obtain a Detailed History:**
  * Explore the nature and timing of the awareness episode (e.g., hearing voices, pain, or feeling paralysis).
* **Exclude Other Causes:**
  * Consider differential diagnoses such as delirium, ICU psychosis, or vivid dreams.

**Document the Event**

* **Comprehensive Documentation:**
  * Record the patient’s account, including time, duration, and symptoms.
* **Report the Incident:**
  * Notify the anaesthetic team and document in the patient’s notes for future reference.

***

#### **2. Early Management**

**Debrief the Patient**

* **Explanation of the Event:**
  * Provide an understandable explanation of why awareness might have occurred, avoiding overly technical language.
* **Clarify Details:**
  * Explain anaesthetic techniques used and whether mitigating factors (e.g., hemodynamic instability) contributed.

**Psychological Support**

* **Immediate Counselling:**
  * Offer emotional support and acknowledge potential distress.
* **Referral to Specialist:**
  * Arrange early access to psychological or psychiatric support if symptoms of distress are significant.

**Review and Investigate**

* **Root Cause Analysis:**
  * Perform a structured review of the incident, including:
    * Anaesthetic record (drug dosages, end-tidal anaesthetic levels).
    * Equipment checks for malfunction.
    * Monitoring adequacy (e.g., depth of anaesthesia monitors, neuromuscular blockade).
* **Team Discussion:**
  * Conduct a case review with the anaesthesia team to identify areas for improvement.

***

#### **3. Postoperative Follow-Up**

**Short-Term Follow-Up**

* **Psychological Assessment:**
  * Screen for acute stress reactions, such as anxiety, insomnia, or flashbacks.
* **Information Provision:**
  * Provide educational resources about intraoperative awareness to normalize the experience and reduce stigma.

**Long-Term Follow-Up**

* **Monitor for PTSD:**
  * Be vigilant for symptoms such as hypervigilance, nightmares, or avoidance behaviors.
  * Refer to a psychologist or psychiatrist if PTSD develops.
* **Ongoing Communication:**
  * Maintain regular contact with the patient to address concerns and ensure resolution of distress.

**Anaesthetic Planning for Future Procedures**

* **Record in Medical History:**
  * Highlight the history of awareness for consideration in future anaesthetic planning.
* **Enhanced Anaesthetic Techniques:**
  * Discuss options such as BIS monitoring, preoperative sedation, and amnestic agents for subsequent surgeries.
* **Preoperative Discussion:**
  * Involve the patient in planning to build trust and reduce anxiety.

***

#### **4. System-Level Considerations**

**Quality Improvement**

* **Audit and Review:**
  * Contribute findings to hospital-wide quality improvement initiatives.
* **Staff Education:**
  * Train anaesthetists in recognizing and preventing intraoperative awareness.

**Reporting**

* **Incident Reporting System:**
  * Report the event to relevant governing bodies (e.g., ANZCA, AAGA registry) for broader analysis and learning.

***

#### **Summary**

Management of intraoperative awareness requires immediate empathetic support, thorough investigation, and structured follow-up to address psychological sequelae and prevent recurrence. Early referral to psychological services and integration into quality improvement systems are essential for comprehensive care."

</details>

<details>

<summary>GS_1.16 Discuss the potential causes, prevention and management of postoperative delirium</summary>

#### **Potential Causes**

**1. Patient-Related Factors**

* **Age and Frailty:**
  * Elderly patients are at higher risk due to reduced cognitive reserve.
* **Pre-existing Cognitive Impairment:**
  * Dementia or mild cognitive impairment significantly increases risk.
* **Comorbidities:**
  * Chronic illnesses, such as cardiovascular disease, diabetes, or depression.
* **Substance Use:**
  * Alcohol use disorder or withdrawal.
  * Chronic use of benzodiazepines or opioids.

**2. Surgery-Related Factors**

* **Type of Surgery:**
  * High-risk procedures (e.g., cardiac, orthopaedic, or major abdominal surgeries).
* **Duration of Surgery:**
  * Prolonged operative time leading to increased stress and metabolic demand.
* **Perioperative Hypoxia or Hypotension:**
  * Reduced cerebral perfusion and oxygenation.

**3. Anaesthetic-Related Factors**

* **Depth of Anaesthesia:**
  * Both inadequate and excessive depth may contribute.
* **Specific Drugs:**
  * Use of anticholinergics, benzodiazepines, or high doses of opioids.
* **Postoperative Pain Management:**
  * Poorly controlled pain or excessive sedation.

**4. Environmental Factors**

* **Hospital Environment:**
  * Sleep disruption, sensory deprivation, or overstimulation in ICU or ward.
* **Inadequate Postoperative Care:**
  * Delayed mobilization or lack of routine cognitive assessments.

***

#### **Prevention**

**1. Preoperative Strategies**

* **Risk Identification:**
  * Screen for risk factors using tools like the Confusion Assessment Method (CAM).
* **Optimize Comorbidities:**
  * Stabilize chronic conditions and ensure appropriate medication use.
* **Patient Education:**
  * Inform patients and families about potential delirium risk and warning signs.

**2. Intraoperative Measures**

* **Optimized Anaesthetic Techniques:**
  * Use short-acting agents and avoid high doses of benzodiazepines or anticholinergics.
  * Employ BIS monitoring to maintain an appropriate depth of anaesthesia.
* **Ensure Physiological Stability:**
  * Maintain normothermia, oxygenation, and hemodynamic stability.

**3. Postoperative Interventions**

* **Early Mobilization:**
  * Encourage ambulation to reduce immobility-associated delirium.
* **Pain Control:**
  * Provide multimodal analgesia to minimize opioid use.
* **Minimize Environmental Stressors:**
  * Reduce noise and ensure adequate lighting to promote circadian rhythm.
* **Hydration and Nutrition:**
  * Address dehydration and electrolyte imbalances promptly.

***

#### **Management**

**1. Initial Assessment**

* **Identify Delirium:**
  * Use standardized tools like CAM or the 4AT to confirm diagnosis.
* **Evaluate Underlying Causes:**
  * Conduct a thorough review of patient history, medications, and recent events.

**2. Treat Underlying Causes**

* **Metabolic and Physiological Factors:**
  * Correct hypoxia, hypotension, hypoglycemia, or electrolyte imbalances.
* **Infections:**
  * Treat sepsis or localized infections with appropriate antibiotics.
* **Medications:**
  * Discontinue or adjust potentially causative drugs (e.g., benzodiazepines, anticholinergics).

**3. Non-Pharmacological Management**

* **Reorientation:**
  * Engage patients in frequent reorientation activities (e.g., clocks, calendars).
* **Optimize Environment:**
  * Promote sleep hygiene and provide hearing aids or glasses if needed.
* **Family Involvement:**
  * Encourage familiar interactions to reduce distress.

**4. Pharmacological Management (if necessary)**

* **Indications:**
  * Severe agitation posing risk to self or others, or unresponsive to non-pharmacological measures.
* **Medications:**
  * Haloperidol or atypical antipsychotics (e.g., olanzapine, quetiapine) in low doses.
  * Avoid benzodiazepines unless delirium is due to alcohol or benzodiazepine withdrawal.

***

#### **Follow-Up**

* **Post-Discharge Care:**
  * Monitor for persistent cognitive deficits and refer for geriatric or psychiatric evaluation if needed.
* **Prevent Recurrence:**
  * Address modifiable risk factors and educate caregivers about delirium prevention.

***

#### **Summary**

Postoperative delirium arises from a combination of patient, surgical, and environmental factors. Prevention involves optimizing preoperative, intraoperative, and postoperative care, with a focus on minimizing risk factors. Management prioritizes addressing underlying causes, employing non-pharmacological strategies, and using pharmacological interventions only when necessary."

</details>